Trial Details
COMPLETEDBasic Information
| Clinical ID | c4258 |
|---|---|
| Identifier | NCT00783692 |
| Trial Title | Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: vedolizumab|OTHER: Placebo |
Participant Information
| Sponsor | Millennium Pharmaceuticals, Inc. |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2008-12 |
|---|---|
| Primary Completion Date | 2012-03 |
| Completion Date | 2012-05 |